Amryt Announces the Appointment of Sheila Frame as President Americas
April 06, 2021 02:00 ET
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, April 6, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Submits a New Drug Application to the US Food and Drug Administration for Oleogel-S10* (Filsuvez®)
March 31, 2021 02:00 ET
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 31, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS
March 30, 2021 02:00 ET
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 30, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Announces Validation of its MAA by the EMA for Oleogel-S10* (Filsuvez®)
March 29, 2021 02:00 ET
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 29, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing...
Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy
March 23, 2021 03:00 ET
|
Amryt Pharma plc
Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy DUBLIN, Ireland, and Boston MA, March 23, 2021, Amryt (Nasdaq: AMYT,...
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
March 22, 2021 03:00 ET
|
Amryt Pharma plc
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin) DUBLIN, Ireland, and Boston MA, March 22, 2021, Amryt (Nasdaq: AMYT, AIM:...
Director/PDMR Shareholding
March 15, 2021 06:00 ET
|
Amryt Pharma plc
Amryt Pharma plc Director/PDMR Shareholding The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the...
Exercise of Options and Total Voting Rights
March 12, 2021 02:00 ET
|
Amryt Pharma plc
Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to...
Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
March 11, 2021 06:30 ET
|
Amryt Pharma plc
Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 11, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Director/PDMR Shareholding
March 08, 2021 13:00 ET
|
Amryt Pharma plc
Grant of Options and Notification of Transactions by Persons Discharging Managerial Responsibilities DUBLIN, Ireland, and Boston MA, March 8, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global,...